Table 3.
Inhibition of subcutaneous HR8348 adenocarcinoma growth by ASODN
| Group | Diameter of tumor (cm) | Rate of tumorigenicity (%) |
| Control | 1.00 ± 0.08 | 100 (10/10) |
| Liposome-RC15 | 0.95 ± 0.07 | 100 (10/10) |
| Liposome-AEGFR | 0.80 | 20 (2/10) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.